Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians

Fluid biomarkers improve the diagnostic accuracy in dementia and provide an objective measure potentially useful as a therapeutic response in clinical trials. The role of fluid biomarkers in patient care is a rapidly evolving field. Here, we provide a review and recommendations regarding the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa-Neto, Pedro, Hsiung, Ging-Yuek Robin, Masellis, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980280/
https://www.ncbi.nlm.nih.gov/pubmed/24565514
http://dx.doi.org/10.1186/alzrt223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980280/
https://www.ncbi.nlm.nih.gov/pubmed/24565514
http://dx.doi.org/10.1186/alzrt223

Ejemplares similares